By answering the following questions, you can see whether you might be able to participate in the ASPIRE trial. There is no obligation and further trial requirements will be explained by the study doctor.
Are you 40 years or older?
Have you been diagnosed with idiopathic pulmonary fibrosis (IPF) within the last 5 years?
Are you currently treated with any licensed IPF medication?
Are you currently treated with a stable dose of nintedanib (Ofev)?
Are you currently treated with pirfenidone (for example Esbriet)?
You do not currently meet the trial requirements for participation in the ASPIRE trial
Based on your responses, it appears that you do not currently meet the trial requirements for participation in the ASPIRE trial. If you have a confirmed diagnosis of IPF and are still interested in taking part in this trial, please contact your doctor who may be able to advise you further. If there are changes in your answers to any of these questions in the future, please check again to re-evaluate your possibility of participating.
Patients treated with certain medications cannot participate in the ASPIRE trial
Buloxibutid may affect blood levels of other drugs and therefore patients treated with certain medications (for example pirfenidone) cannot participate in this trial. If you have a confirmed diagnosis of IPF and are interested in taking part in a trial, please contact your doctor who may be able to advise you further. If there are changes in your answers to any of these questions in the future, please check again to re-evaluate your possibility of participating.
You may be eligible for taking part in the ASPIRE trial
Based on your responses provided, you may be eligible for taking part in the ASPIRE trial. Click here to view a summary of the ASPIRE IPF trial which you can download and print or email to your doctor to find out if the ASPIRE IPF trial is an option for you.
